Relationship between the levels of serum IL-17, Hcy and clinicopathological features in patients with gastric cancer and its diagnostic value
LIU Zheng1 GONG Xiangliang2 XU Ai′fang1
1.Department of Laboratory, Tangshan People′s Hospital, Hebei Province, Tangshan 063000, China;
2.Department of Oncology, Tangshan Third Hospital, Hebei Province ,Tangshan 063000, China
Abstract：Objective To explore the relationship between serum interleukin (IL)-17, homocysteine (Hcy) levels and pathological features in patients with gastric cancer and its clinical diagnostic value. Methods A total of 80 patients with gastric cancer admitted to Tangshan People′s Hospital from March 2015 to March 2017 were selected as gastric cancer group, another 80 patients with benign gastric lesions were selected as the benign lesion group, and 60 volunteers with health examination during the same period were selected as the normal control group. The serum IL-17 and Hcy levels in each group were compared, and the relationship between serum IL-17 and Hcy and pathological features in gastric cancer patients was analyzed. ROC curve was drawn to evaluate the predictive value of combined IL-17 and Hcy detection for gastric cancer. Results The serum IL-17 and Hcy levels in gastric cancer group were higher than those in the benign lesion group and the normal control group, and serum IL-17 and Hcy levels in the benign lesion group were higher than those in the normal control group (P ＜ 0.05). The serum IL-17 and Hcy levels in the gastric cancer patients were related to infiltration depth, lymph node metastasis and TNM stage (P ＜ 0.05). The area under the curve, sensitivity, specificity and Youden index of IL-17 combined with Hcy detection were all higher than those of IL-17 detection and Hcy detection separately (P ＜ 0.05). Conclusion IL-17 and Hcy are highly expressed in the serum of patients with gastric cancer, which are related to the depth of invasion, lymph node metastasis and TNM stage of gastric cancer. Combined detection of IL-17 and Hcy can improve the diagnosis effect of early gastric cancer.
刘征1 宫向良2 徐爱芳1. 胃癌患者血清IL-17、Hcy表达水平与临床病理特征的关系及其诊断价值[J]. 中国医药导报, 2020, 17(23): 91-94.
LIU Zheng1 GONG Xiangliang2 XU Ai′fang1. Relationship between the levels of serum IL-17, Hcy and clinicopathological features in patients with gastric cancer and its diagnostic value. 中国医药导报, 2020, 17(23): 91-94.
[1] Yhm C，de Steur WO，Hartgrink HH，et al. Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial [J]. Ann Surg，2018，268（6）：1008-1013.
[2] Namikawa T，Maeda H，Kitagawa H，et al. Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage Ⅲ gastric cancer： a multicenter phase Ⅱ study （TOSA trial） protocol [J]. Bmc Cancer，2018，18（1）：186.
[3] Mankaney G，Leone P，Cruise M，et al. Gastric cancer in FAP：a concerning rise in incidence [J]. Fam Cancer，2017，16（3）：371-376.
[4] Jiang YX，Yang SW，Li PA，et al. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms [J]. Oncogene，2017，36（9）：1256-1264.
[5] 郭佳琦，钱鑫.IL-17F与肿瘤关系的研究进展[J].免疫学杂志，2017，8（1）：78-83.
[6] Shiao PK，Lie A，Chong HY. Meta-analysis of homocysteine-related factors on the risk of colorectal cancer [J]. Oncotarget，2018，9（39）：25681-25697.
[7] Padovani D，Hessani A，Castillo FT，et al. Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases [J]. Nat Commun，2016，7：13386.
[8] Merkow RP，Herrera G，Goldman DA，et al. Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer： Association with Pathology and Outcome [J]. Ann Surg Oncol，2017，24（12）：3658-3666.
[9] Yong HK，Jeon SW，Su YN，et al. Long-Term Outcome After Endoscopic Submucosal Dissection for Early Gastric Cancer in Non-neoplastic Pathology Results [J]. Dig Diss Sci，2017，62（5）：1313-1320.
[10] Wang J，Liu Y，Sun W，et al. Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer [J]. Cancer Biomark，2018，21（4）：805-812.
[11] Zhao AJ，Qian YY，Sun H，et al. Screening for gastric cancer with magnetically controlled capsule gastroscopy in asymptomatic individuals [J]. Gastrointest Endosc，2018， 88（3）：466-474.
[12] Samiei G，Yip WK，Leong PP，et al. Association between polymorphisms of interleukin-17A G197A and interleukin-17F A7488G and risk of colorectal cancer [J]. J Cancer Res Ther，2018，14（9）：299-305.
[13] Kwiecien I，Stelmaszczyk-Emmel A，Polubiec-Kownacka M，et al. Elevated regulatory T cells，surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans [J]. Cancer Immunl Immunother，2017，66（2）：161-170.
[14] Lereclus E，Tout M，Girault A，et al. A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen [J]. Bmc Cancer，2017，17（1）：220.
[15] Gao YW，Xu M，Xu Y，et al. Effect of three common IL-17 single nucleotide polymorphisms on the risk of developing gastric cancer [J]. Oncol Lett，2015，9（3）：1398-1402.
[16] 宋静静.外源性IL-17对胃癌细胞生物学特性的影响及其机制研究[J].中国肿瘤，2018，27（11）：867-873.
[17] Chaturvedi S，Hoffman RM，Bertino JR. Exploiting methionine restriction for cancer treatment [J]. Biocheml Pharmacol，2018，154：170-173.
[18] Chang SC，Goldstein BY，Mu L，et al. Plasma Folate，Vitamin B12，and Homocysteine and Cancers of the Esophagus，Stomach，and Liver in a Chinese Population [J]. Nutr Cancer，2015，67（2）：212-223.
[19] 薛辉，辛凤池，穆素恩，等.血清Hcy，叶酸和维生素B12在胃癌及其癌前疾病中的作用[J].现代生物医学进展，2017，17（15）：2896-2899.
[20] 朱向超.血清同型半胱氨酸在胃癌诊断中的价值及其与胃癌分期的相关性研究[D].济南：山东大学，2016.
2020, Vol. 17 
京公网安备 11010502046598号